Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
RISE Act of 2021
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed onto the Ad Hoc Group FY 2022 funding request for a program level of at least $46.1 billion for the NIH, a $3.2 billion increase, or an increase of BRDPI + 5% (7.4%), over the FY 2021 program level. (This funding level includes the full $496 million NIH is scheduled to receive in FY 2022 from the Innovation Account established in the 21st Century Cures Act for specific programs.) As part of its recommendation for the NIH funding level, the coalition is also recommending a robust commitment to discretionary spending programs, including the Labor-HHS-Education allocation, as well as emergency supplemental funding to support Covid-19 related expenses on both pandemic- and non-pandemic research. AACP joined the Friends of AHRQ in sending a letter to leadership of the House and Senate Appropriations Committees to request no less than $500 million for AHRQ in FY22. AACP signed onto a Friends of NICHD letter to House and Senate Appropriations Committees leaders endorsing the Ad Hoc Group for Medical Research FY 2022 funding recommendation, which would give the NIH $46.1 billion, a $3.2 billion increase over the agencyas FY 2021 level, and calling for NICHD to receive a proportionate funding increase, bringing its funding to $1.7 billion in Fiscal Year (FY) 2022, an increase of $117 million over FY 2021. The letter also calls for direct emergency supplemental appropriation for NICHD to support pandemic-related research. AACP joined a Friends of NIDDK letter to House and Senate Leadership and House and Senate Chairs and Ranking Members of Appropriations Committees and Labor-HHS Subcommittees to support the research communityas FY 2022 NIH funding recommendation of at least $46.111 billion, a $3.177 billion increase over the comparable FY 2021 funding level for the NIH, which would allow for the NIHas base budget to keep pace with the biomedical research and development price index (BRDPI) of 2.3 % and allow meaningful growth of 5%. We request a proportionate increase for the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) of at least $157 million for a total of $2.289 billion in FY 2022. The letter also also strongly encourages Congress to provide supplemental emergency funding of $10 billion for NIH, ensure dedicated support for the NIDDK to enable critical COVID-related research, and support research recovery from the impact of the pandemic. AACP signed letter urging Acting HHS Secretary Cochran to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). The proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19. AACP signed onto letter requesting that Congress appropriate $50 million in Fiscal Year (FY) 2022 for the CDC and NIH to conduct research on firearm injury and mortality prevention. AACP signed onto a letter led by Research!America asking for support for the Investment to Spark the Economy (RISE) Act (H.R.869/S.289) and request and support full funding for the initiatives it would create in any relevant proposal that advances. AACP signed onto a letter led by FOVA expressing FY22 funding recommendations.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2022 · second_quarter · Q2
AACP joined FASHP Letter addressed to House and Senate leadership asking for passage of the Bipartisan Safer Communities Act, legislation that will take critical steps to curb the gun violence epidemic
AACP signed onto a Friends of HRSA FY23 Appropriations Request sent to House and Senate Appropriations Committees supporting increased funding for HRSA. AACP signed onto FASHP (Federation of Associations of Schools of the Health Professions) letter sent to House and Senate Appropriations leadership asking that they provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC) and $25 million for the National Institutes of Health (NIH) to conduct public health research into firearm morbidity and mortality prevention. AACP signed onto Coalition for Health Funding FY 2023 Labor-HHS-Ed 302(b) Organization Sign-on Letter sent to House and Senate Appropriations leadership. AACP signed onto letter sent by Research!America to House and Senate Appropriations leadership asking that they work towards securing a robust 302(b) funding allocation for the Labor-HHS-Education Subcommittee to meet the very real research funding needs before us. A healthy 302(b) allocation will help ensure robust funding for important health agencies in the Labor-HHS-Education Subcommittee including NIH, CDC, AHRQ, BARDA and ARPA-H.
Source: Senate LDA
Indian Health Service Health Professions Tax Fairness Act of 2021
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
S. 2874 The Indian Health Service Health Professions Tax Fairness Act Signed onto letter in support of S 2874 the Indian Health Service Health Professions Tax Fairness Act of 2021 sent to congressional leadership led by AI/AN Health Partners. Thank you letter to Senators Cortez Masto and Murkowski for introducing S. 2874, the Indian Health Service Health Professions Tax Fairness Act of 2021. This important bill would amend the tax code to provide health care professionals who receive student loan repayments and scholarships from the Indian Health Service (IHS) the same tax-free status enjoyed by those who receive National Health Service Corps (NHSC) loan repayments.
RISE Act of 2021
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed onto the Ad Hoc Group FY 2022 funding request for a program level of at least $46.1 billion for the NIH, a $3.2 billion increase, or an increase of BRDPI + 5% (7.4%), over the FY 2021 program level. (This funding level includes the full $496 million NIH is scheduled to receive in FY 2022 from the Innovation Account established in the 21st Century Cures Act for specific programs.) As part of its recommendation for the NIH funding level, the coalition is also recommending a robust commitment to discretionary spending programs, including the Labor-HHS-Education allocation, as well as emergency supplemental funding to support Covid-19 related expenses on both pandemic- and non-pandemic research. AACP joined the Friends of AHRQ in sending a letter to leadership of the House and Senate Appropriations Committees to request no less than $500 million for AHRQ in FY22. AACP signed onto a Friends of NICHD letter to House and Senate Appropriations Committees leaders endorsing the Ad Hoc Group for Medical Research FY 2022 funding recommendation, which would give the NIH $46.1 billion, a $3.2 billion increase over the agencyas FY 2021 level, and calling for NICHD to receive a proportionate funding increase, bringing its funding to $1.7 billion in Fiscal Year (FY) 2022, an increase of $117 million over FY 2021. The letter also calls for direct emergency supplemental appropriation for NICHD to support pandemic-related research. AACP joined a Friends of NIDDK letter to House and Senate Leadership and House and Senate Chairs and Ranking Members of Appropriations Committees and Labor-HHS Subcommittees to support the research communityas FY 2022 NIH funding recommendation of at least $46.111 billion, a $3.177 billion increase over the comparable FY 2021 funding level for the NIH, which would allow for the NIHas base budget to keep pace with the biomedical research and development price index (BRDPI) of 2.3 % and allow meaningful growth of 5%. We request a proportionate increase for the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) of at least $157 million for a total of $2.289 billion in FY 2022. The letter also also strongly encourages Congress to provide supplemental emergency funding of $10 billion for NIH, ensure dedicated support for the NIDDK to enable critical COVID-related research, and support research recovery from the impact of the pandemic. AACP signed letter urging Acting HHS Secretary Cochran to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). The proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19. AACP signed onto letter requesting that Congress appropriate $50 million in Fiscal Year (FY) 2022 for the CDC and NIH to conduct research on firearm injury and mortality prevention. AACP signed onto a letter led by Research!America asking for support for the Investment to Spark the Economy (RISE) Act (H.R.869/S.289) and request and support full funding for the initiatives it would create in any relevant proposal that advances. AACP signed onto a letter led by FOVA expressing FY22 funding recommendations.
The Heroes Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Joined TFAH, APHA, ASTHO, BPC Action, NACCHO, and PHAB in an organizational sign-on letter to congressional leadership in support of increased, sustained annual funding for state/local/tribal/territorial public health infrastructure. Signed onto letter to the Senate (McConnell, Schumer, Murkowski, Udall) led by AI/AN Partners to ask for funding for tribes and IHS to effectively respond to COVID-19, including at least a match of funding level in H.R. 6800, the HEROES Act, for the Bureau of Indian Affairs and Indian Health Service. The letter also urged inclusion of S. 2871, the Indian Health Service Health Professions Tax Fairness Act, in the next coronavirus response bill.
Addressing COVID-19 Health Disparities Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed Ad Hoc group letter urging Congressional leaders to include at least $15.5 billion in emergency funding for NIH, to support research and costs of lost productivity associated with COVID-19, in supplemental legislation, as included in the Senate HEALS Act. AACP signed a letter led by Friends of AHRQ endorsing Congressman Don Beyer's bill H.R. 8067. The bill would direct AHRQ to conduct or support research on the most critical health system issues for COVID-19,
Addressing COVID-19 Health Disparities Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed a letter led by Friends of AHRQ endorsing Congressman Don Beyer's bill H.R. 8067. The bill would direct AHRQ to conduct or support research on the most critical health system issues for COVID-19, including on the expansion and efficacy of telehealth, evaluating and identifying potential weaknesses in the health system that increase racial and ethnic disparities in COVID-19 infection rates and develop strategies for mitigating them, and creating protocols that ensure that vulnerable groups have timely access to safe and effective COVID-19 vaccines. AACP signed Ad Hoc group letter urging Congressional leaders to include at least $15.5 billion in emergency funding for NIH, to support research and costs of lost productivity associated with COVID-19, in supplemental legislation, as included in the Senate HEALS Act.
Indian Health Service Health Professions Tax Fairness Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Joined TFAH, APHA, ASTHO, BPC Action, NACCHO, and PHAB in an organizational sign-on letter to congressional leadership in support of increased, sustained annual funding for state/local/tribal/territorial public health infrastructure. Signed onto letter to the Senate (McConnell, Schumer, Murkowski, Udall) led by AI/AN Partners to ask for funding for tribes and IHS to effectively respond to COVID-19, including at least a match of funding level in H.R. 6800, the HEROES Act, for the Bureau of Indian Affairs and Indian Health Service. The letter also urged inclusion of S. 2871, the Indian Health Service Health Professions Tax Fairness Act, in the next coronavirus response bill.
Extreme Risk Protection Order Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE - H.R. 1236 the Extreme Risk Protection Order Act Contacted by Representative Carbajal to sign on in support of their introduction of H.R. 1236 the Extreme Risk Protection Order Act.
Investing for the People Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Investing for the People Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
REACH Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by friends of AHRQ as House and Senate begin Fiscal 2020 conference negotiations amongst appropriators urging them to support a final funding level equal to, or above the House-passed level of $358.2 million for AHRQ. HOUSE/SENATE - H.R. 2328 Reauthorizing and Extending Americas Community Health Act Signed coalition letter led by NIDDK to House and Senate leaders (Reps. Nancy Pelosi and Kevin McCarthy and Sens. Mitch McConnell and Charles Schumer) urging reauthorization of the Special Diabetes Program through H.R. 2328 Reauthorizing and Extending America's Community Health Act or the "REACH Act." HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by the Ad Hoc Group Steering Committee for Medical Research urging House and Senate appropriators to ensure quick enactment of Labor-HHS-Education appropriations bill that provides robust, sustained funding for medical research. This letter has an emphasis on NIH funding. SENATE - Funding Bill FY20 Signed onto Giffords Coalition letter urging Senate leadership to include the House passed Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies funding bill, which includes $50 million for the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to conduct research into gun violence.
Leading Infrastructure for Tomorrow’s America Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Leading Infrastructure for Tomorrow’s America Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
American Dream and Promise Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
American Dream and Promise Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE - H.R. 987/Discussion of Pharmacy Education Visiting Office of office Rep. Lucy McBath in response to an amendment offered by the representative to H.R. 987. The amendment calls for DHHS and DoEd to do all needed outreach to make sure faculty and students at colleges of pharmacy have all necessary materials about generic drugs and biosimilar biological products. AACP welcomes the representatives support for pharmacists and pharmacy students.
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
United States Public Health Service Modernization Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - UNITED STATES PUBLIC HEALTH SERVICE MODERNIZATON ACT (S. 2629) Signed onto letter led by the American Indian/Alaska Natives (AI/AN) Partners coalition urging the Senate Health, Education, Labor and Pensions (HELP) Committee to approve S. 2629, the United States Public Health Service Modernization Act of 2019. The bill would create a Ready Reserve Corps for the Public Health Services Commissioned Corps. HOUSE - 21ST CENTURY CURES 2.0 ACT The Pharmacy Health Information Technology Collaborative submitted comments to cures2@mail.house.gov in support of pharmacists being recognized as health care practitioners in all telehealth and digital health technology proposals put forward, payment codes for their services provided. SENATE - Letter to Senate Indian Affairs Committee Signed AI/AN Partners letter to the Senate Indian Affairs Committee in support of Rear Admiral Michael Weahkees nomination as Director of IHS. HHS - OIG Signed onto AKS Proposed Rule on Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements Proposed Rule (OIG-0936-AA10-P) letter lead by pharmacy organizations.
Indian Health Service Health Professions Tax Fairness Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Senate - Cosponsor S.2871 Indian Health Service Health Professions Tax Fairness Act of 2019 Signed onto letter urging Senators to cosponsor S. 2871 the Indian Health Service Health Professions Tax Fairness Act of 2019. The bill seeks to amend the tax code to provide health care professionals who receive student loan repayments and scholarships from the Indian Health Service (IHS) the same tax-free status enjoyed by those who receive National Health Service Corps (NHSC) loan repayments. Under the IHS and NHSC programs, health care professionals provide needed care and services to underserved populations.
Dream Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
Dream Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
AACP signed onto letter from JCPP+ group to new czar Dr. Jha of The White House Coronavirus Task Force outlining pharmacist's priorities related to COVID-19 response. AACP signed onto letter led by FASHP to House and Senate leadership encouraging the inclusion of health professions education and training programs in your legislative efforts to address the mental health challenges facing our country. AACP signed onto letter sent to House and Senate leadership urging Congress to act and safeguard American's access to COVID-19 testing, treatments and vaccines and to prevent further dismantling of critical elements of our public health response. AACP signed onto National Pharmacy Associations COVID Vaccine Leadership Council letter to HHS asking for Clarification of Pharmacy PREP Act Authorities.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2022 · first_quarter · Q1
AACP signed onto a Friends of AHRQ coalition letter sent to house and senate leadership in support of FY2023 priorities. AACP signed onto a support letter led by Friends NCHS supporting FY2023 funding priorities.
JCPP+ CEOs signed a letter on behalf of their organizations groups calling for the removal of a limitation placed on the emergency use authorization (EUA) of COVID-19 antivirals by the Food and Drug Administration (FDA). The limitation prevents pharmacists from ordering the medications. AACP signed on to a letter let by the GTMRx coalition sent to House leadership supporting the Right Drug Now Dose Act. AACP signed onto a letter led by the JCPP+ group sent to Senate leadership supporting the confirmation of Dr. Robert Califf as Commissioner of the Food and Drug Administration. Letter sent to Sens. Patty Murray and Richard Burr from FASHP to Comment on Draft of PREVENT Act requesting to add language to allow health profession students to vaccinate in the PREVENT Pandemics Act. AACP signed onto a FASHP coalition led letter to Senate HELP leadership in support of the PREVENT Pandemics Act. Met with Katie Reisbig of HHS HCORE program to discuss pharmacy fee reimbursement issues for pharmacists.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2021 · fourth_quarter · Q4
S. 2874 The Indian Health Service Health Professions Tax Fairness Act Signed onto letter in support of S 2874 the Indian Health Service Health Professions Tax Fairness Act of 2021 sent to congressional leadership led by AI/AN Health Partners. Thank you letter to Senators Cortez Masto and Murkowski for introducing S. 2874, the Indian Health Service Health Professions Tax Fairness Act of 2021. This important bill would amend the tax code to provide health care professionals who receive student loan repayments and scholarships from the Indian Health Service (IHS) the same tax-free status enjoyed by those who receive National Health Service Corps (NHSC) loan repayments.
Fiscal Year 2022 appropriations Signed onto Research!America led letter to congressional leaders requesting prompt action to complete Fiscal Year 2022 (FY22) appropriations. Signed onto letter to congressional leadership led by Research!America urging them to avoid another continuing resolution (CR) by completing the Fiscal Year 2022 appropriations process before the current CR expired on December 3, 2021 Signed onto letter led by the CDC Coalition to House and Senate Appropriations Committee leaders urging them to include at least the House-passed level of $10.5 B for CDC in any final FY 2022 appropriations package. Ad Hoc Group sign-on letter to House and Senate Appropriations Committee leadership, urging swift passage of the House-passed $46.4 billion for the NIH base budget for FY 2022.
Meeting with the Director of the Center for Medicare & National Pharmacy Organizations to Discuss Federal Recognition and Payment for Pharmacist-Provided Patient Care Services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2021 · third_quarter · Q3
AACP joined a letter Sent to Secretary of HHS urging HHS to extend the Center for Medicare & Medicaid Innovation (CMMI) Part D Enhanced Medication Therapy Management Model (EMTM, the Model) that is set to expire on December 31, 2021.
Filing targets: Health & Human Services, Dept of (HHS)
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2021 · second_quarter · Q2
AACP Policy Task Force follow-up letter to HHS on Pharmacy Education's continued response and role in the roll out of the COVID-19 Vaccine and overall public health care needs. AACP Policy Task Force follow-up letter to the White House on Pharmacy Education's continued response and role in the roll out of the COVID-19 Vaccine and overall public health care needs. AACP joined an Ad Hoc Group letter to congressional leaders encouraging them to include investments in the infrastructure underpinning the medical research enterprise as they consider legislation to strengthen the nation's infrastructure and bolster economic recovery.
AACP submitted comments to NIH NOT-OD-21-066, "Inviting Comments and Suggestions to Advance and Strengthen Racial Equity, Diversity, and Inclusion in the Biomedical Research Workforce and Advance Health Disparities and Health Equity Research," suggesting policies and actions to support a diverse biomedical research workforce and health disparities research.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2021 · first_quarter · Q1
AACP signed onto the Ad Hoc Group FY 2022 funding request for a program level of at least $46.1 billion for the NIH, a $3.2 billion increase, or an increase of BRDPI + 5% (7.4%), over the FY 2021 program level. (This funding level includes the full $496 million NIH is scheduled to receive in FY 2022 from the Innovation Account established in the 21st Century Cures Act for specific programs.) As part of its recommendation for the NIH funding level, the coalition is also recommending a robust commitment to discretionary spending programs, including the Labor-HHS-Education allocation, as well as emergency supplemental funding to support Covid-19 related expenses on both pandemic- and non-pandemic research. AACP joined the Friends of AHRQ in sending a letter to leadership of the House and Senate Appropriations Committees to request no less than $500 million for AHRQ in FY22. AACP signed onto a Friends of NICHD letter to House and Senate Appropriations Committees leaders endorsing the Ad Hoc Group for Medical Research FY 2022 funding recommendation, which would give the NIH $46.1 billion, a $3.2 billion increase over the agencyas FY 2021 level, and calling for NICHD to receive a proportionate funding increase, bringing its funding to $1.7 billion in Fiscal Year (FY) 2022, an increase of $117 million over FY 2021. The letter also calls for direct emergency supplemental appropriation for NICHD to support pandemic-related research. AACP joined a Friends of NIDDK letter to House and Senate Leadership and House and Senate Chairs and Ranking Members of Appropriations Committees and Labor-HHS Subcommittees to support the research communityas FY 2022 NIH funding recommendation of at least $46.111 billion, a $3.177 billion increase over the comparable FY 2021 funding level for the NIH, which would allow for the NIHas base budget to keep pace with the biomedical research and development price index (BRDPI) of 2.3 % and allow meaningful growth of 5%. We request a proportionate increase for the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) of at least $157 million for a total of $2.289 billion in FY 2022. The letter also also strongly encourages Congress to provide supplemental emergency funding of $10 billion for NIH, ensure dedicated support for the NIDDK to enable critical COVID-related research, and support research recovery from the impact of the pandemic. AACP signed letter urging Acting HHS Secretary Cochran to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). The proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19. AACP signed onto letter requesting that Congress appropriate $50 million in Fiscal Year (FY) 2022 for the CDC and NIH to conduct research on firearm injury and mortality prevention. AACP signed onto a letter led by Research!America asking for support for the Investment to Spark the Economy (RISE) Act (H.R.869/S.289) and request and support full funding for the initiatives it would create in any relevant proposal that advances. AACP signed onto a letter led by FOVA expressing FY22 funding recommendations.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2020 · fourth_quarter · Q4
Led a letter through FASHP sent to Acting DHS Secretary oppose the new guidance released by U.S. Immigration and Customs Enforcement (ICE) that prohibits international students from returning to or remaining in the United States if the institutions they attend adopt online-only instruction models amid the COVID-19 pandemic. Joined an open letter from scientific and educational societies to White House, Department of Homeland Security and Department of State to request withdrawal of proposed ICE modification of exemptions for international students attending online programs during the COVID-19 pandemic.
Letter to President-elect Biden from more than 160 organization expressing appreciation for the President-elect's long standing support for medical research, outlining broad foundational principles to reinforce medical research as a top national priority, highlighting the continued need for supplemental COVID-19 funds, and urging a continued strong commitment to meaningful growth across disciplines and disease areas in the administration's FY 2022 budget request and beyond. Letter lead by the American Society for Microbiology to demonstrate support for leading with the science, with data, and with evidence-based public health recommendations, and the importance of deferring to the expertise of Dr. Fauci and other public health officials who are prioritizing science-based public health strategies to address the COVID-19 pandemic. Letter to NIH Human Fetal Tissue Research Ethics Advisory Board in support of use of human fetal tissue in biomedical research. Letter to Sec. HHS Azar thanking them for renewing the public health emergency (PHE) declaration as a result of the COVID-19 pandemic for another 90 days. Letter sent to Sen. Warner to urge their support on the inclusion of language that establishes emergency pharmacist provider status in the next COVID-19 legislative package that is currently being negotiated. AACP signed on to comments led by the Coalition to Advance Maternal Therapeutics, in response to a docket from the FDA Office of Women's Health requests input and comments regarding strategic priorities within OWH. The letter urges FDA OWH to make inclusion of pregnant and lactating women in clinical trials a strategic priority. AACP and the leaders of its Public Health SIG submitted comments directed to Secretary Azar regarding the Viral Hepatitis National Strategic Plan: A Roadmap to Elimination (2021-2025) (Hepatitis Plan), Federal Register document citation 85 FR 60813. AACP commended the plan and emphasized the positive role pharmacists can play in preventing, testing and treating viral hepatitis, as well as its openness to working with federal agencies on the draft plan's objectives. AACP submitted comments to DHS Docket No. ICEB-2019-0006-0001, "Comments in Response to Establishing a Fixed Time Period of Admission and an Extension of Stay Procedure for Nonimmigrant Academic Students, Exchange Visitors, and Representatives of Foreign Information Media," in opposition to the proposed change. AACP and the AACP Substance Use Disorder SIG submitted comments in support of interpreting the SUPPORT Act to allow pharmacists to administer appropriately prescribed long-acting injectable (LAI)
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2020 · third_quarter · Q3
Letter sent to Sen. Warner to urge their support on the inclusion of language that establishes emergency pharmacist provider status in the next COVID-19 legislative package that is currently being negotiated. Letter to Sec. HHS Azar thanking them for renewing the public health emergency (PHE) declaration as a result of the COVID-19 pandemic for another 90 days. Letter to NIH Human Fetal Tissue Research Ethics Advisory Board in support of use of human fetal tissue in biomedical research. AACP signed on to comments led by the Coalition to Advance Maternal Therapeutics, in response to a docket from the FDA Office of Women's Health requests input and comments regarding strategic priorities within OWH. The letter urges FDA OWH to make inclusion of pregnant and lactating women in clinical trials a strategic priority. Letter lead by the American Society for Microbiology to demonstrate support for leading with the science, with data, and with evidence-based public health recommendations, and the importance of deferring to the expertise of Dr. Fauci and other public health officials who are prioritizing science-based public health strategies to address the COVID-19 pandemic.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2020 · second_quarter · Q2
Signed onto DACA Health Professions Letter sent to Congressional leadership urging them to maintain work authorization for individuals currently in Deferred Action for Childhood Arrivals (DACA) status during the COVID-19 national emergency.
Signed onto letter led by National Association of County and City Health Officials (NACCHO) sent to Senators Smith and Booker thanking them for introducing the bill, which is a companion to the House version included in the Heroes Act. Senators Tina Smith (D-MN) and Cory Booker (D-NJ) introduced the Senate version of the Public Health Workforce Loan Repayment Act. The bill would provide loan repayment for professionals who serve two years in a local, state or tribal health department.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2020 · first_quarter · Q1
HOUSE/SENATE - FY21 NIH Funding Recommendation AACP signed onto a letter by the Ad Hoc Committee For Medical Research recommending $44.7 billion for the NIH, a $3 billion (7.2%) increase over the FY 2020 program level. This funding level includes the full $404 million NIH is scheduled to receive in FY 2021 from the Innovation Account established in the 21st Century Cures Act for specific programs. HOUSE/SENATE - Friends of VA FY21 Funding Request AACP endorsed the FOVA FY 21 recommendation for the VA research program asking for $860 million for the VA Medical and Prosthetic Research program in FY 2021, a $60 million increase over the appropriated level in FY 2020. HOUSE/SENATE - FY21 Funding Request AACP signed onto a Friends of NCHS Fiscal Year 2020 recommending in support of the National Center on Health Statistics (NCHS) recommending an appropriation of at least $189 million for the agency. HOUSE/SENATE - ECHO FY21 Funding Request AACP signed onto to a letter requesting appropriations of $180 million in funding for the Environmental influences on Child Health Outcomes (ECHO) program in FY21. HOUSE - Friends of AHRQ Funding AACP signed onto a letter led by the Friends of AHRQ coalition requesting $471 million appropriation for the Agency for Healthcare Research and Quality (AHRQ) for FY21. HOUSE - Giffords Coalition on Gun Safety AACP signed onto a letter asking for $50 million in funding to be shared by the CDC and NIH to conduct public health research into firearm morbidity and mortality prevention. House/Senate - COVID-19 Response AACP signed onto a letter led by the American Society for Microbiology, Association of American Universities, Association of Public Health Laboratories, and Trust for Americas Health calling on appropriators to review the response to COVID-19 pandemic.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · fourth_quarter · Q4
SENATE - UNITED STATES PUBLIC HEALTH SERVICE MODERNIZATON ACT (S. 2629) Signed onto letter led by the American Indian/Alaska Natives (AI/AN) Partners coalition urging the Senate Health, Education, Labor and Pensions (HELP) Committee to approve S. 2629, the United States Public Health Service Modernization Act of 2019. The bill would create a Ready Reserve Corps for the Public Health Services Commissioned Corps. HOUSE - 21ST CENTURY CURES 2.0 ACT The Pharmacy Health Information Technology Collaborative submitted comments to cures2@mail.house.gov in support of pharmacists being recognized as health care practitioners in all telehealth and digital health technology proposals put forward, payment codes for their services provided. SENATE - Letter to Senate Indian Affairs Committee Signed AI/AN Partners letter to the Senate Indian Affairs Committee in support of Rear Admiral Michael Weahkees nomination as Director of IHS. HHS - OIG Signed onto AKS Proposed Rule on Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements Proposed Rule (OIG-0936-AA10-P) letter lead by pharmacy organizations.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · third_quarter · Q3
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by friends of AHRQ as House and Senate begin Fiscal 2020 conference negotiations amongst appropriators urging them to support a final funding level equal to, or above the House-passed level of $358.2 million for AHRQ. HOUSE/SENATE - H.R. 2328 Reauthorizing and Extending Americas Community Health Act Signed coalition letter led by NIDDK to House and Senate leaders (Reps. Nancy Pelosi and Kevin McCarthy and Sens. Mitch McConnell and Charles Schumer) urging reauthorization of the Special Diabetes Program through H.R. 2328 Reauthorizing and Extending America's Community Health Act or the "REACH Act." HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by the Ad Hoc Group Steering Committee for Medical Research urging House and Senate appropriators to ensure quick enactment of Labor-HHS-Education appropriations bill that provides robust, sustained funding for medical research. This letter has an emphasis on NIH funding. SENATE - Funding Bill FY20 Signed onto Giffords Coalition letter urging Senate leadership to include the House passed Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies funding bill, which includes $50 million for the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to conduct research into gun violence.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · second_quarter · 2A
Status of pharmacists as health care providers for Medicare/Medicaid services
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · second_quarter · Q2
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
AACP joined a CAMT letter to the Biden Administration asking that they harmonize policies across agencies to set inclusion of pregnant and lactating people in clinical trials as the default; asking NIH and FDA to require sponsors to justify exclusion of pregnant and lactating people from trials; and encouraging the Administration to extend the PRGLAC charter or establish a committee with a similar charter to ensure implementation of PRGLAC task force recommendations. AACP Policy Task Force Letter to the White House RE: Pharmacy Education in COVID-19 Vaccine Rollout AACP signed onto a letter from the Coalition to Advance Maternal Therapeutics in response to Docket No. CDC-2021-0021, Notice of meeting and request for comment, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention Letter from JCCP+ group to HHS requesting to include pharmacists in PREP Act expansion. AACP signed onto a AI/AN partners letter to the White House expressing the qualities the next IHS director should have.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AACP signed Ad Hoc group letter urging Congressional leaders to include at least $15.5 billion in emergency funding for NIH, to support research and costs of lost productivity associated with COVID-19, in supplemental legislation, as included in the Senate HEALS Act. AACP signed a letter led by Friends of AHRQ endorsing Congressman Don Beyer's bill H.R. 8067. The bill would direct AHRQ to conduct or support research on the most critical health system issues for COVID-19,
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, White House Office
AACP signed a letter led by Friends of AHRQ endorsing Congressman Don Beyer's bill H.R. 8067. The bill would direct AHRQ to conduct or support research on the most critical health system issues for COVID-19, including on the expansion and efficacy of telehealth, evaluating and identifying potential weaknesses in the health system that increase racial and ethnic disparities in COVID-19 infection rates and develop strategies for mitigating them, and creating protocols that ensure that vulnerable groups have timely access to safe and effective COVID-19 vaccines. AACP signed Ad Hoc group letter urging Congressional leaders to include at least $15.5 billion in emergency funding for NIH, to support research and costs of lost productivity associated with COVID-19, in supplemental legislation, as included in the Senate HEALS Act.
Joined an open letter from scientific and educational societies to White House, Department of Homeland Security and Department of State to request withdrawal of proposed ICE modification of exemptions for international students attending online programs during the COVID-19 pandemic. Led a letter through FASHP sent to Acting DHS Secretary oppose the new guidance released by U.S. Immigration and Customs Enforcement (ICE) that prohibits international students from returning to or remaining in the United States if the institutions they attend adopt online-only instruction models amid the COVID-19 pandemic.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office
Joined TFAH, APHA, ASTHO, BPC Action, NACCHO, and PHAB in an organizational sign-on letter to congressional leadership in support of increased, sustained annual funding for state/local/tribal/territorial public health infrastructure. Signed onto letter to the Senate (McConnell, Schumer, Murkowski, Udall) led by AI/AN Partners to ask for funding for tribes and IHS to effectively respond to COVID-19, including at least a match of funding level in H.R. 6800, the HEROES Act, for the Bureau of Indian Affairs and Indian Health Service. The letter also urged inclusion of S. 2871, the Indian Health Service Health Professions Tax Fairness Act, in the next coronavirus response bill.
Joined TFAH, APHA, ASTHO, Big Cities Health Coalition, and NACCHO in a sign on letter to HHS Secretary Azar urging him to strengthen and affirm the role of CDC. Joined the American Society for Microbiology, American Public Health Association, Association of Public Health Laboratories, National Association of County and City Health Officials and Trust for Americaas Health, on a letter urging HHS Secretary Azar to extend the COVID-19 public health emergency. The letter asks HHS to renew the current public health emergency (PHE) declaration for at least an additional 90 days before it expires on July 25. It is imperative that the federal government continue to deploy all resources and authorities necessary to protect the public, spur the development of medical countermeasures, and assist states and localities as they continue to respond to this urgent situation. Pharmacy HIT Collaborative comments to DEA 2181: Reopened Electronic Prescriptions for Controlled Substances; Interim Final Rule.
Coalition for Health Funding call with Chris Bigelow, House Appropriations Committee Deputy Staff Director. Letter to House and Senate Military Construction, VA, and Related Agencies Appropriations Subcommittee leaders urging inclusion of at least $50 million for VA research in future COVID-19 supplemental funding bills. The letter was submitted on May 21 by the Friends of the VA, with AACP as a signatory. Signed a letter sent to Senate and House leadership (Senators Mitch McConnell and Chuck Schumer, and House leaders Nancy Pelosi and Kevin McCarthy), led by the Friends of NIDDK, requesting emergency funds for NIDDK be included in next COVID-19 relief bill, to investigate COVID-19 and comorbidities associated with diseases and research areas in NIDDK's portfolio. AACP endorsed the Research Investment to Secure the Economy (RISE) Act, a bipartisan piece of legislation which authorizes appropriations to science agencies of $26 billion to offset the costs of lost productivity to research labs during the pandemic.
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CMS - PROVIDER STATUS FOR PHARMACISTS Signed onto comment letter led by American Pharmacists Association to CMS Secretary Verma requesting that pharmacists gain provider status during the duration of the public health crisis of COVID-19.
SENATE - White House ONDCP HIDTA DFC AACP signed onto a letter requesting that the HIDTA and DFC programs remain at the office of the National Drug Control Policy.
NIH/FDA - CAMT COVID-19 AACP signed onto a letter led by the Coalition to Advance Maternal Therapeutics (CAMT) urging NIH and FDA to ensure that pregnant women and lactating women are included in all research for the development of vaccines and therapeutics related to COVID-19. White House - Fetal Tissue research related to COVID-19 AACP signed onto a letter urging President Trump to lift the restrictions on federally funded research using human fetal tissue immediately. House/Senate/White House - FASHP COVID-19 AACP signed onto a letter led by the Federation of Associations of Schools of the Health Professions (FASHP) urging the House and Senate to consider the unique economic and educational needs of the nations health professions schools and students, and the associations that represent them, in any federal legislative or stimulus package. CMS - Comments on Proposed Rule AACP signed onto comments led by the Pharmacy Quality Alliance (PQA) to CMS on proposed rule for Medicare and Medicaid Programs: Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-inclusive Care for the Elderly.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto a letter led by the Ad Hoc Group for Medical Research urging quick enactment of a Labor-HHS-Education appropriations bill that provides robust, sustained funding for medical research. HOUSE/SENATE - APPROPRIATIONS COMMITTEE AND LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto a letter from the Friends of AHRQ urging support for a final AHRQ funding level of $358 million dollars for FY20, equal to the amount passed by the House Appropriations Committee. SENATE - SENATE LEADERSHIP Signed onto a letter led by the Friends of NIDDK to authorize five health care and public health extenders - the Community Health Center Fund (CHCF), the Special Diabetes Program (SDP), the Special Diabetes Program for Indians (SDPI), Teaching Health Centers Graduate Medical Education (THCGME), and the National Health Service Corps (NHSC), before their authorizations expired in December 2019. House/Senate - Interior Appropriations Letters Signed onto letter led by AI/AN Partners sent to Senate and House Interior Appropriations Subcommittee urging them to fund the IHS at the highest amount possible as they conference the FY 2020 Interior appropriations bill.
Senate - Cosponsor S.2871 Indian Health Service Health Professions Tax Fairness Act of 2019 Signed onto letter urging Senators to cosponsor S. 2871 the Indian Health Service Health Professions Tax Fairness Act of 2019. The bill seeks to amend the tax code to provide health care professionals who receive student loan repayments and scholarships from the Indian Health Service (IHS) the same tax-free status enjoyed by those who receive National Health Service Corps (NHSC) loan repayments. Under the IHS and NHSC programs, health care professionals provide needed care and services to underserved populations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Status of pharmacists as health care providers for Medicare/Medicaid services
HOUSE - H.R. 1236 the Extreme Risk Protection Order Act Contacted by Representative Carbajal to sign on in support of their introduction of H.R. 1236 the Extreme Risk Protection Order Act.
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
HOUSE - H.R. 987/Discussion of Pharmacy Education Visiting Office of office Rep. Lucy McBath in response to an amendment offered by the representative to H.R. 987. The amendment calls for DHHS and DoEd to do all needed outreach to make sure faculty and students at colleges of pharmacy have all necessary materials about generic drugs and biosimilar biological products. AACP welcomes the representatives support for pharmacists and pharmacy students.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office